Illuccix Total Body PET-CT for Prostate Cancer
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Male
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase < 1
Waitlist Available
Sponsor: BAMF Health
No Placebo Group
Trial Summary
What is the purpose of this trial?Illuccix will be used per the prescribing instructions for PET-CT imaging on the United Imaging scanner uEXPLORER to establish a standard scanning protocol.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Low DoseExperimental Treatment1 Intervention
3 mCi dose of 68Ga-PSMA-11 (Illuccix) and a total body PET-CT scan for 4-6 min scan time.
Group II: High doseExperimental Treatment1 Intervention
7 mCi dose of 68Ga-PSMA-11 (Illuccix) and a total body PET-CT scan for 4-6 min scan time.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
BAMF HealthGrand Rapids, MI
Loading ...
Who is running the clinical trial?
BAMF HealthLead Sponsor
Telix Pharmaceuticals (Innovations) Pty LimitedIndustry Sponsor
Telix International Pty LtdIndustry Sponsor